Skip to main content
. 2015 May 18;2015:854706. doi: 10.1155/2015/854706

Table 4.

Distribution of CD8+ lymphocyte subpopulations in peripheral blood of pSS patients and controls.

Patients 1I-controls 2II-pSS Abs− 3III-pSS Abs+ P * P * P *
I-II I-III II-III
CD8+ lymphocyte population            
 CD8highCD57+CD27+            
  %4 5.306 ± 3.899 5.329 ± 5.431 8.239 ± 8.239 NS NS 0.032
  A. count# 34.26 ± 29.11 27.05 ± 33.57 42.59 ± 33.12 NS NS 0.011
 CD8highCD57+CD27−            
  %4 22.67 ± 13.33 25.52 ± 17.42 27.40 ± 19.55 NS NS NS
  A. count# 150.6 ± 119.7 143.4 ± 157.7 155.2 ± 136.8 NS NS NS
 CD8highCD57−CD27+            
  %4 59.13 ± 17.54 46.51 ± 22.00 47.16 ± 22.29 0.026 NS NS
  A. count# 387.3 ± 211.4 227.9 ± 186.6 224.8 ± 129.3 0.0003 0.005 NS
 CD8highCD57−CD27−            
  %4 13.10 ± 8.112 22.60 ± 15.37 17.18 ± 11.20 0.024 NS NS
  A. count# 85.79 ± 73.99 119.1 ± 126.7 99.46 ± 85.96 NS NS NS
 CD8+FoxP3            
  %5 10.59 ± 15.16 5.881 ± 6.673 6.498 ± 7.939 NS NS NS
  A. count# 91.42 ± 126.1 51.19 ± 86.72 50.49 ± 60.37 NS NS NS

1I group: healthy controls; 2II group: pSS patients without anti-SSA/SSB; 3III group: pSS patients with anti-SSA and/or anti-SSB; %4: proportion of all CD8high lymphocytes; %5: proportion of all CD8+ lymphocytes. A. count#: absolute count of cells in 1 μL of blood. *Mann-Whitney test. NS: not significant.